Works matching IS 2160763X AND DT 2020 AND VI 9 AND IP 7
Results: 14
Correction.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 7, p. 889, doi. 10.1002/cpdd.861
- Publication type:
- Article
Pharmacokinetics and Bioequivalence Estimation of Two Formulations of Alfuzosin Extended‐Release Tablets.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 7, p. 780, doi. 10.1002/cpdd.860
- By:
- Publication type:
- Article
Evaluation of Absolute Oral Bioavailability and Bioequivalence of Ribociclib, a Cyclin‐Dependent Kinase 4/6 Inhibitor, in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 7, p. 855, doi. 10.1002/cpdd.853
- By:
- Publication type:
- Article
Application of a Backpropagation Artificial Neural Network in Predicting Plasma Concentration and Pharmacokinetic Parameters of Oral Single‐Dose Rosuvastatin in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 7, p. 867, doi. 10.1002/cpdd.809
- By:
- Publication type:
- Article
Phase 1 Study to Evaluate the Effect of the Investigational Anticancer Agent Sapanisertib on the QTc Interval in Patients With Advanced Solid Tumors.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 7, p. 876, doi. 10.1002/cpdd.808
- By:
- Publication type:
- Article
Pharmacokinetics and Bioequivalence of Clopidogrel Hydrogen Sulfate Tablets in Fed and Fasted Conditions: An Open‐Label, Randomized, Semireplicated Crossover Study in Healthy Chinese Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 7, p. 813, doi. 10.1002/cpdd.804
- By:
- Publication type:
- Article
Levocetirizine Oral Disintegrating Tablet: A Randomized Open‐Label Crossover Bioequivalence Study in Healthy Japanese Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 7, p. 805, doi. 10.1002/cpdd.791
- By:
- Publication type:
- Article
The Effect of Food on the Single‐Dose Bioavailability and Tolerability of the Highest Marketed Strength of Duloxetine.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 7, p. 797, doi. 10.1002/cpdd.759
- By:
- Publication type:
- Article
Safety, Tolerability, Pharmacokinetics, and Food Effects on TAC‐302 in Healthy Participants: Randomized, Double‐Blind, Placebo‐Controlled, Single‐Dose and Multiple‐Dose Studies.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 7, p. 821, doi. 10.1002/cpdd.776
- By:
- Publication type:
- Article
A Phase 1, Randomized, Placebo‐Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Subcutaneous Tezepelumab in Healthy Japanese Men.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 7, p. 833, doi. 10.1002/cpdd.775
- By:
- Publication type:
- Article
Platelet Function: Meloxicam Intravenous in Whole Blood Samples From Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 7, p. 841, doi. 10.1002/cpdd.772
- By:
- Publication type:
- Article
Single‐Dose Pharmacokinetics, Safety, and Tolerability of Avadomide (CC‐122) in Subjects With Mild, Moderate, or Severe Renal Impairment.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 7, p. 785, doi. 10.1002/cpdd.760
- By:
- Publication type:
- Article
The Bioequivalence of Tafamidis 61‐mg Free Acid Capsules and Tafamidis Meglumine 4 × 20‐mg Capsules in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 7, p. 849, doi. 10.1002/cpdd.789
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 7, p. 775, doi. 10.1002/cpdd.681
- Publication type:
- Article